https://www.selleckchem.com/pr....oducts/PD-0325901.ht
However, these were only statistically significant in the case of intraoperative complications (intra p = 0.036, post p = 0.579). Intraoperative complications (n = 7), conversions (n = 4) and transfusions (n = 4) occurred in pcR-RPLND patients only. After a median follow-up of 16.3 months (IQR 7.5-35. there were no recurrences or deaths. R-RPLND displays a valuable, minimally invasive treatment option in mTGCT. However, R-RPLND is challenging and pcR-RPLND especially bears a considerable risk of complications. This operation should
Like
Comment
Share
